Green tea EGCG, T cells, and T cell-mediated autoimmune diseases

被引:97
作者
Wu, Dayong [1 ]
Wang, Junpeng [1 ]
Pae, Munkyong [1 ]
Meydani, Simin Nikbin [1 ,2 ]
机构
[1] Tufts Univ, Nutr Immunol Lab, Jean Mayer USDA Human Nutr Res Ctr Aging, Boston, MA 02111 USA
[2] Tufts Univ, Dept Pathol, Sackler Grad Sch Biochem Sci, Boston, MA 02111 USA
基金
美国食品与农业研究所;
关键词
T cells; Autoimmunity; Multiple sclerosis; Rheumatoid arthritis; Green tea; EGCG; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; COLLAGEN-INDUCED ARTHRITIS; GROWTH-FACTOR-BETA; INTERCELLULAR-ADHESION MOLECULE-1; INTERFERON-GAMMA PRODUCTION; NECROSIS-FACTOR-ALPHA; NF-KAPPA-B; RHEUMATOID-ARTHRITIS; TGF-BETA;
D O I
10.1016/j.mam.2011.10.001
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
One of the proposed health benefits of consuming green tea is its protective effect on autoimmune diseases. Research on the immunopathogenesis of autoimmune diseases has made significant progression in the past few years and several key concepts have been revised. T cells, particularly CD4(+) T helper (Th) cells, play a key role in mediating many aspects of autoimmune diseases. Upon antigenic stimulation, naive CD4(+) T cells proliferate and differentiate into different effector subsets. Th1 and Th17 cells are the pro-inflammatory subsets of Th cells responsible for inducing autoimmunity whereas regulatory T cells (Treg) have an antagonistic effect. Green tea and its active ingredient, epigallocatechin-3-gallate (EGCG), have been shown to improve symptoms and reduce the pathology in some animal models of autoimmune diseases. Whether or not EGCG's effect is mediated through its impact on Th17 and Treg development has not been studied. We conducted a series of studies to investigate EGCG's effect on CD4(+) T cell proliferation and differentiation as well as its impact on the development of autoimmune disease. We first observed that EGCG inhibited CD4(+) T cell expansion in response to either polyclonal or antigen specific stimulation. We then determined how EGCG affects naive CD4(+) T cell differentiation and found that it impeded Th1 and Th17 differentiation and prevented IL-6-induced inhibition on Treg development. We further demonstrated that EGCG inhibited Th1 and Th17 differentiation by downregulating their corresponding transcription factors (STAT1 and T-bet for Th1, and STAT3 and ROR gamma t for Th17). These effects provide further explanation for previous findings that administration of EGCG by gavage to experimental autoimmune encephalomyelitis (EAE) mice, an animal model for human multiple sclerosis (MS), reduced the clinical symptoms, brain pathology, and proliferation and TNF-alpha production of encephalitogenic T cells. Upon further investigating the working mechanisms for EGCG's protective effect in the EAE model, we showed that dietary EGCG dose-dependently attenuated the disease's severity. This protective effect of EGCG is associated with the suppressed proliferation of autoreactive T cells, reduced production of pro-inflammatory cytokines, decreased Th1 and Th17, and increased Treg populations in lymphoid tissues and central nervous system. EGCG-induced shifts in CD4(+) T cell subsets in EAE mice are accompanied by the corresponding changes in their regulator molecules. Recent studies have also highlighted the critical role of Th17/Treg balance in the pathogenesis of rheumatoid arthritis (RA). EGCG has been shown to be anti-inflammatory and protective in several studies using animal models of inflammatory arthritis, but research, at the best, only to start looking into the mechanisms with a focus on T cells. Overall, future research should fully incorporate the current progress in autoimmunity into the study design to expand the power of evaluating EGCG's efficacy in treating autoimmune diseases. Data from human studies are essentially absent and thus are urgently needed. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:107 / 118
页数:12
相关论文
共 115 条
  • [1] Functional diversity of helper T lymphocytes
    Abbas, AK
    Murphy, KM
    Sher, A
    [J]. NATURE, 1996, 383 (6603) : 787 - 793
  • [2] Interleukins 1β and 6 but not transforming growth factor-β are essential for the differentiation of interleukin 17-producing human T helper cells
    Acosta-Rodriguez, Eva V.
    Napolitani, Giorgio
    Lanzavecchia, Antonio
    Sallusto, Federica
    [J]. NATURE IMMUNOLOGY, 2007, 8 (09) : 942 - 949
  • [3] Green tea epigallocatechin-3-gallate mediates T cellular NF-κB inhibition and exerts neuroprotection in autoimmune encephalomyelitis
    Aktas, O
    Prozorovski, T
    Smorodchenko, A
    Savaskan, NE
    Lauster, R
    Kloetzel, PM
    Infante-Duarte, C
    Brocke, S
    Zipp, F
    [J]. JOURNAL OF IMMUNOLOGY, 2004, 173 (09) : 5794 - 5800
  • [4] ENCEPHALITOGENIC T-CELLS IN THE B10.PL MODEL OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS (EAE) ARE OF THE TH-1 LYMPHOKINE SUBTYPE
    ANDO, DG
    CLAYTON, J
    KONO, D
    URBAN, JL
    SERCARZ, EE
    [J]. CELLULAR IMMUNOLOGY, 1989, 124 (01) : 132 - 143
  • [5] CYTOKINES IN THE CENTRAL-NERVOUS-SYSTEM OF MICE DURING CHRONIC RELAPSING EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS
    BAKER, D
    ONEILL, JK
    TURK, JL
    [J]. CELLULAR IMMUNOLOGY, 1991, 134 (02) : 505 - 510
  • [6] Effects of green tea polyphenols on murine transplant-reactive T cell immunity
    Bayer, J
    Gomer, A
    Demir, Y
    Amano, H
    Kish, DD
    Fairchild, R
    Heeger, PS
    [J]. CLINICAL IMMUNOLOGY, 2004, 110 (01) : 100 - 108
  • [7] Begolka WS, 1998, J IMMUNOL, V161, P4437
  • [8] Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells
    Bettelli, E
    Carrier, YJ
    Gao, WD
    Korn, T
    Strom, TB
    Oukka, M
    Weiner, HL
    Kuchroo, VK
    [J]. NATURE, 2006, 441 (7090) : 235 - 238
  • [9] TH-17 cells in the circle of immunity and autoimmunity
    Bettelli, Estelle
    Oukka, Mohamed
    Kuchroo, Vijay K.
    [J]. NATURE IMMUNOLOGY, 2007, 8 (04) : 345 - 350
  • [10] TGFβ1 and Treg cells:: alliance for tolerance
    Bommireddy, Ramireddy
    Doetschman, Thomas
    [J]. TRENDS IN MOLECULAR MEDICINE, 2007, 13 (11) : 492 - 501